Pharmacoepidemiology and Drug Safety

Article	Citations
	113
Issue Information	73
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second‐Line Treatment of Advanced Non–Small Cell Lung Cancer	54
Advancing Health Equity in Europe: Explore, Tailor, Implement, and Evaluate (ETIE)—A Framework of Diversity and Fairness in Pharmacoepidemiologic Research	53
External validity in distributed data networks	44
Correction to “Effect of tramadol and DOACs with special attention to dabigatran on concomitant use, on the risk of mayor bleeding using BIFAP database in Spain”	39
Validation of diagnosis codes for chorioamnionitis in medical encounter data, 2013–2018	37
Issue Information	37
Quantitative Benefit–Risk Assessment of Vaccination Against COVID‐19: A Systematic Review	36
Antibiotics and Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Analysis of Brazilian Pharmacovigilance Registries	34
Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data	34
Mixed Impact of Direct Healthcare Professional Communications When Considering Proximal Outcomes and the Targeted Population: A Systematic Review	33
ORAL PRESENTATION	28
Data Resource Profile: The Danish National Hospital Medicine Register	28
Management of epilepsy in Lebanon: Medication reviews and drug‐related problems	26
International trends in prescription opioid sales among developed and developing economies, and the impact of the COVID‐19 pandemic: A cross‐sectional analysis of 66 countries	25
Causal Forests Versus Inverse Probability of Treatment Weighting to Adjust for Cluster‐Level Confounding: A Parametric and Plasmode Simulation Study Based on US	24
Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study	24
Warfarin‐Associated Bleeding and Thromboembolic Events in Sub‐Saharan Africa: A Systematic Review and Meta‐Analysis	23
Issue Information	23
Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark	22
Optimizing therapeutic decision‐making for off‐label medicines use: A scoping review and consensus recommendations for improving practice and research+	22
Letter to the Editor	22
Dipeptidyl Peptidase 4 Inhibitors: Novel Therapeutic Agents in the Management of Type II Diabetes Mellitus	19
	19

All Lines Is the Right Approach: Selecting Patient Lines of Therapy for an External Comparator Arm	19
Issue Information	19
Comorbidity influence in observational studies: Why ignore the real world?	18
Use of gastrointestinal prokinetics and the risk of parkinsonism: A population‐based case‐crossover study	18
Comment on: Exploring the impact of design criteria for reference sets on performance evaluation of signal detection algorithms: The case of drug–drug interactions	17
Validation of a Major and Clinically Relevant Nonmajor Bleeding Phenotyping Algorithm on Electronic Health Records	17
	16
	16
Use of Potentially Nephrotoxic Drugs in Type 2 Diabetes Patients on SGLT2i: A Trajectories Analysis	16
Valproate utilisation trends among women of childbearing potential in Ireland between 2014 and 2019: A drug utilisation study using interrupted time series	15
Overlap Weights for Binary Outcomes: A Performance Assessment	15
Corrigendum to “A Brief Report on Proposed Areas of International Harmonization of Real‐World Evidence Relevance, Reliability and Quality Standards Among Medical Product Regulators”	15
Comparing survival in trial‐ versus routine‐care advanced urothelial cancer patients on immune checkpoint blockade	15
Prenatal and Early‐Life Anti‐Infectives and Obesity at Age 7 Years	15
Titel: Risk of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Treated With Immune Checkpoint Inhibitors Compared to Other Antineoplastic Medications: A Nationwide Study	15
Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databases	14
Metadata for Data dIscoverability aNd Study rEplicability in obseRVAtional Studies (MINERVA): Development and Pilot of a Metadata List and Catalogue in Europe	14
Validity of ICD‐10‐based algorithms to identify patients with influenza in inpatient and outpatient settings	14
A comparison of confounder selection and adjustment methods for estimating causal effects using large healthcare databases	14
Advancing Research Transparency and Reproducibility in Pharmacoepidemiology	14
Identifying Extended‐Release Naltrexone Treatment for Opioid Use Disorder in US Medicaid Data	14
Probabilistic precision calculations for the planning of studies assessing negative binomial rates	13
Impact of Lookback Duration on the Performance of a Claims‐Based Frailty Proxy in Women With Stage I–III Breast Cancer	13
The Challenges for Pharmacoepidemiologists Identifying Migraine in Electronic Healthcare Data Sources: A Systematic Literature Review	13
An individual segmented trajectory approach for identifying opioid use patterns using longitudinal dispensing data	13
Federated analyses of multiple data sources in drug safety studies	13
Trends in the Dispensing of Oral Anti‐Cancer Medications Across Australia Over 10 Years	13
Issue Information	13
Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke	13
Validation of new medication use algorithms as proxies for worsening disease activity in patients with juvenile idiopathic arthritis	12
Post‐Market Evidence for Cancer Medicines in Regulatory and Clinical Decision‐Making: A Scoping Review	12
Letter to the Editor re Davis et al., 2023: BELpREG, the first of its kind real‐world data source on medication use in pregnancy in Belgium	12
An Emulated Target Trial Case Study of Real‐World Overall Survival With Second‐Line Maintenance Niraparib Versus Active Surveillance in Patients With Recurrent Ovarian Cancer	12
Issue Information	12
Validation of alopecia coding in US claims data among women of childbearing age	12
Hazard Ratios and Alternative Effect Measures: An Applied Illustration	12
Hypertension medication from guidelines to practice: A cohort study in western Iran	12
Recommendations to Enable Broader Use of Real‐World Evidence to Inform Decision‐Making Throughout Pharmacovigilance Signal Management	11
Validation of an algorithm to identify fractures among patients within the Veterans Health Administration	11
Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation	11
Review of Mother–Infant Linkage Algorithms in Health Care Data Sources	11
Safety of BNT162b2 mRNA COVID ‐19 Vaccine Batches: A Nationwide Cohort Study	11
Clozapine‐Associated Neutropenia Prevalence in a Large, Integrated Healthcare System	11
The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling Population	11
Concurrent Alcohol Use and the Relative Risk of Community‐Acquired Pneumonia Associated With Anticholinergic and Non‐Anticholinergic Neurocognitively Active Medication Receipt: A National Nested Case–	11
Development and validation of an electronic health records‐based opioid use disorder algorithm by expert clinical adjudication among patients with prescribed opioids	11
Impact of Antibiotic Shortages on Antibiotic Utilisation in the Community	11
The impact of hydrocodone rescheduling on utilization, abuse, misuse, and overdose deaths	11
Assessing medical product safety during pregnancy using parameterizable tools in the sentinel distributed database	10
Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe	10

Association between pre‐admission anticoagulation and in‐hospital death, venous thromboembolism, and major bleeding among hospitalized COVID‐19 patients in Japan	10
Issue Information	10
Adherence to prescription proton pump inhibitor therapy amongst individuals diagnosed with Barrett's esophagus	10
Glucagon‐like Peptide‐1 Receptor Agonists in Asthma Exacerbations: An Application of High‐Dimensional Iterative Causal Forest to Identify Subgroups	10
Valproic Acid‐Induced Congenital Disorders, an Analysis in EudraVigilance and a Literature Review of Valproic Acid Utilization During Pregnancy	10
Characterization of SARS‐CoV‐2 Diagnostic Tests and Liver Function Tests Among Patients With COVID‐19 Diagnosed in Outpatient Settings Using Administrative Healthcare	10
Issue Information	10
Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations	10
Consistency between the National Patient Register and the Swedish Cancer Register	9
Use of Omalizumab for Pediatric Asthma After US Food and Drug Administration Expanded Indications	9
Issue Information	9
10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology	9
Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies	9
Effectiveness and use of reverse transcriptase polymerase chain reaction point of care testing in a large‐scale COVID‐19 surveillance system	9
Percutaneous left atrial appendage occlusion and risk of stroke, hospitalized bleeding and death in Medicare beneficiaries	9
Association of Quinolone Exposure in the First‐Trimester of Pregnancy and the Risk of Major Congenital Malformations: A Health Administrative Database Study in Japan	9
Validation of diagnostic coding for bronchiectasis in an electronic health record system in Hong Kong	9
The risk of miscarriage after COVID‐19 vaccination before and during pregnancy	9
Effectiveness and Safety of Reduced and Standard Initial Doses of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Retrospective Study in Taiwan	9
Drug interactions in hospital prescriptions in Denmark: Prevalence and associations with adverse outcomes	9
Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned	9
ISPE20 Author Index	8
A meta‐analysis assessing the prevalence of drug–drug interactions among hospitalized patients	8
Dipeptidyl Peptidase‐4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus and End‐Stage Renal Disease Requiring Dialysis	8
Trends in clomiphene citrate and gonadotropins use in women with infertility between 2010 and 2017: A population‐based study in France	8
A drug utilization study of thiocolchicoside‐containing medicinal products for systemic use in France and Italy: A cross‐sectional electronic medical records database study	8
Comparative Safety of Glucagon‐Like Peptide 1 Receptor Agonists ( GLP ‐1‐ RAs ) in Type 2 Diabetes	8
TriNetX Dataworks‐ USA : Overview of a Multi‐Purpose, De‐Identified, Federated Electronic Health Record Real‐World Dat	8
Detecting and Dating Early Non‐live Pregnancy Outcomes: Generation of a Novel Pregnancy Algorithm From Norwegian Linked Health Registries	8
Issue Information	8
ABSTRACTS of the 2024 ISPE Annual Meeting, Berlin, Germany, 24–28 August 2024	8
Descriptive analysis on disproportionate medication errors and associated patient characteristics in the Food and Drug Administration's Adverse Event Reporting System	8
Sex‐specific incidence of hepatitis B virus flares among Bcr‐Abl tyrosine kinase inhibitor users in Taiwan	8
The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE‐D) ISPE‐Endorsed Guidance	8
Patterns of filled prescriptions and the association with risk of drug‐induced death. A population‐based nested case‐control register study	7
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID ‐19 vaccine safety surveillance: Incidence between	7
Prevalence of Polypharmacy in Elderly Population Worldwide: A Systematic Review and Meta‐Analysis	7
Signal detection of COVID‐19 vaccines adverse events using spontaneous reports from South Korea	7
The Effects of Removing the Requirement for Prior Reimbursement Approval on Anticoagulant Use in Ireland: A Cross‐Sectional Study	7
	7
	7
Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual‐level drug dispensing data	7
Issue Information	7
Corrigendum	7
Comparison of record linkage software for deduplicating patient identities in California's Prescription Drug Monitoring Program	7
Validation Assessment of Privacy‐Preserving Synthetic Electronic Health Record Data: Comparison of Original Versus Synthetic Data on Real‐World COVID‐19 Vaccine Effectiveness	7
Adverse drug reaction signal detection methods in spontaneous reporting system: A systematic review	7
Issue Information	7
	7
The Effect of Isoniazid for Tuberculosis Prevention on Pregnancy Risk Among Women Living With HIV on Antiretroviral Treatment and Progestin‐Based Hormonal Contraception	6
Core Concepts in Pharmacoepidemiology: Principled Use of Artificial Intelligence and Machine Learning in Pharmacoepidemiology and Healthcare Research	6
Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population‐Based Cohort Study in Japan	6
SUPPLEMENTARY ABSTRACTS of ICPE 2021, the 37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), 23–25 August, 2021 (virtual)	6
Correction to “A data‐informed approach using individualised dispensing patterns to estimate medicine exposure periods and dose from pharmaceutical claims data”	6
Sampling in the case‐time‐control design among drug users when outcome prevents further treatment	6
Examining the potential direct cardiovascular benefit of tumor‐necrosis factor inhibitor in rheumatoid arthritis: Natural and controlled direct effect analyses	6
Risk of Ischaemic Stroke Varies With Antithrombotic Drugs Use in Proton Pump Inhibitor Users: A Self‐Controlled Case Series Study	6
A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in ty	6
Accuracy and validity of reported opioid prescription days' supply	6
Opioid Use After Hip Fracture and Subsequent Fracture Outcomes: A Self‐Controlled Case Series Design	6
Development and Validation of Claims‐Based Algorithms for Conjunctivitis and Keratitis	6
To wait or not to wait: Weighing the pros and cons of early identification of safety concerns for medications used in pregnancy	6
	6
Rescheduling gabapentinoids had negligible effects on prescribing behaviour by general practitioners in England	6
Real‐World Use of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistenc	6
Core Concepts: Self‐Controlled Designs in Pharmacoepidemiology	6
Prescribing of valproate and oral antiepileptics for women of childbearing age and during pregnancy in Germany between 2010 and 2020	6
Opioid tapering and mental health crisis in older adults	6
Issue Information	6
Real world prescription of beta‐blockers in patients with asthma	6
	6
Preregistration: A Key to Credible Real‐World Evidence Generation	6
Comparing IPCW Models to Adjust for Informative Censoring During COVID ‐19 Using Data From the Cli	5
Risk Factors for Serious Hypotension Induced by Intravenous Acetaminophen in Patients With Hematologic Malignancy	5
Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis	5
Epidemiological Profile of Exogenous Intoxications by Self‐Medication in Brazil: A Decade of Trends and the Impact of the COVID ‐19	5
Severe Cutaneous Adverse Reactions in Hospitalized Children: A Pilot Validation Study	5
Issue Information	5
Kidney function and prescribed dose in middle‐aged and older patients starting selective serotonin reuptake inhibitors	5
Validation studies of Japanese administrative health care data: A scoping review	5

ABSTRACTS of the virtual 2nd Annual African Regional Interest Group Meeting (AfRIG), 11–13 July, 2022	5
Use of Causal Framework to Evaluate Effect of Abuse Deterrent Properties of Extended‐Release Oxycodone on Tampering in a Real‐World Settings	5
Joint longitudinal trajectories of pain intensity and opioid prescription in veterans with back pain	5
Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis	5
Prevalence of self‐medication practices among pregnant women in India: A systematic review and meta‐analysis	5
Issue Information	5
Association of Benzodiazepine Prescription With Short‐Term Prognosis in Elderly Patients Attended in Emergency Department: Results From the EDEN PROJECT	5
Pharmacoepidemiology and Drug Safety's core concepts in pharmacoepidemiology section at 1 year: Where do we go from here?	5
Association of Pharmacist Interventions With Adverse Drug Events and Potential Adverse Drug Events	5
The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures	5
INSIGHT : A Tool for Fit‐for‐Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety	5
The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark	5
Issue Information	5
Mapping Use of High Dose or Long‐Term Oral Glucocorticoids and Steroid‐Sparing Strategies in Adults With Chronic Conditions: A Rapid Scoping Review of Reviews	5
Mobile apps for quick adverse drug reaction report: A scoping review	5
Real‐world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy	5
	5
Overview of global real‐world data sources for pediatric pharmacoepidemiologic research	5
Tell me what you want, what you really really want: Estimands in observational pharmacoepidemiologic comparative effectiveness and safety studies	4
Development of a multivariate prediction model to identify individual case safety reports which require clinical review	4
Stratified analysis in comparative effectiveness studies that emulate randomized trials	4
Risk of ischemic stroke associated with direct oral anticoagulants discontinuation on patients with non‐valvular atrial fibrillation	4
Core concepts in pharmacoepidemiology: Fundamentals of the cohort and case–control study designs	4
Validation of an algorithm for identifying incident cancer cases based on long‐term illness and diagnosis related group program data from the French National Health Insurance Informati	4
Hydrochlorothiazide Use and Risk of Skin Cancer: A Population‐Based Retrospective Cohort Study	4
Development and Application of an Algorithm for Statin‐Induced Myopathy Based on Electronic Health Record‐Derived Structured Elements	4
The Medicines Intelligence Data Platform: A Population‐Based Data Resource From New South Wales, Australia	4
Potentially inappropriate medication use by level of polypharmacy among US Veterans 49–64 and 65–70 years old	4
Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data	4
Impact on In‐ and Out‐of‐Hospital Drug Prescriptions of Including a More Expensive Me‐Too Antidepressant in a Hospital Drug Formulary: a Controlled Longitudinal Study	4
Correction to “An Open‐Source Implementation of Tree‐Based Scan Statistics”	4
A Two‐Step Framework for Validating Causal Effect Estimates	4
Comparative Effectiveness and Safety of Torsemide Versus Furosemide in Older Adults With Heart Failure	4
Pain‐related hospitalization and emergency room visit following initial analgesic prescription after outpatient surgery	4
Validation of ICD‐10 Diagnosis Codes for Identification of Acute Myocardial Infarction From a US Integrated Healthcare System	4
Antidepressant Use Trajectories and Risk of Discontinuation After Adolescents and Young Adult Cancer Diagnosis	4
Issue Information	4
Issue Information	4
Maternal cyclobenzaprine exposure and risk of birth defects in the National Birth Defects Prevention Study (1997–2011) and Birth Defects Study to Evaluate Pregnancy exposureS (2014–2018)	4
Impact and Effectiveness of COVID ‐19 mRNA Vaccination Against COVID	4
Diagnostic Performance of Prostate Cancer Disease‐Specific Phenotypes Identified Using Real‐World Databases: A Systematic Review	4
Aioli: Standardising Drugs in the FDA Adverse Event Reporting System ( FAERS ) to	4
More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching	4
Myopericarditis following COVID‐19 mRNA vaccination	4
Impact of Regulatory Action on Dose Maximalization for Vitamin B6 Dietary Supplements on the Reporting Pattern for Neuropathy	4
Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study	4
Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program	4
Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: A systematic review and meta‐analysis with trial sequential analysis of randomized controlled trials	4
Current Use of Common Data Models in the Nordic Countries	4
STUDENT ABSTRACTS of ISPE's 2024 Mid‐Year Meeting, Orlando, Florida, USA, 14–16 April 2024	4
Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real‐world data	4
Clarifying the causal contrast: An empirical example applying the prevalent new user study design	4
Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance ( ENCePP	4
Increasing Prevalence of Long‐Term Antidepressant Use in Australia: A Retrospective Observational Study	4
Risk of Suicidal Ideation and Behavior Following Early‐Onset Idiopathic Restless Legs Syndrome Treatment	4
	4
Prescriber Adherence to Antihypertensive Prescription Guidelines and the Impact of Patient Socioeconomic Factors: A Cross‐Sectional Study Using Data From the Irish Longitudinal Study on Ageing	4
Evaluating the Impact of Data Standardization on Real‐World Data	4
Implementation of risk minimization measures to reduce the risk of tuberculosis among tumor necrosis factor medication users	4